Okyo Pharma Share Price (OKYO)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Okyo Pharma Limited	LSE:OKYO	London	Ordinary Share	GG00BD3FV870	ORD NPV

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.25	-3.57%	6.75	76,262	08:00:16

Bid Price		Offer Price	High Price	Low Price	Open Price
6.50		7.00	6.75	6.75	6.75

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Mining		-3.76	-0.01		66

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
13:32:39	O	7,319	6.75	GBX

Related Shares
Rio Tinto (RIO), Bhp (BHP), Mila Resources (MILA), African Battery Metals (ABM)

Okyo Pharma (OKYO) Latest News

Okyo Pharma News

Date	Time	Source	Headline
07/5/2021	10:07	UKREG	OKYO Pharma Limited Additional Listing
05/5/2021	11:53	UKREG	OKYO Pharma Limited Publication of a Prospectus
28/4/2021	19:17	ALNC	IN BRIEF: Okyo Pharma posts positive data for OK-201 in animal model
28/4/2021	07:00	UKREG	OKYO Pharma Limited Positive Data in an Animal Model using OK-201
29/3/2021	15:13	ALNC	EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist
29/3/2021	07:00	UKREG	OKYO Pharma Limited Appointment of Chief Scientific Officer
03/3/2021	07:00	UKREG	OKYO Pharma Limited Issue of Equity
01/3/2021	07:00	UKREG	OKYO Pharma Limited Issue of Equity
23/2/2021	14:43	ALNC	IN BRIEF: Okyo Pharma Secures Patent For Treating Ocular Pain
23/2/2021	07:00	RNSNON	OKYO Pharma Limited Patent for treating Ocular Pain and Inflammation

More Okyo Pharma News

Okyo Pharma Investors Okyo Pharma Takeover Rumours

Okyo Pharma (OKYO) Share Charts 1 Year Okyo Pharma Chart
1 Month Okyo Pharma Chart	Intraday Okyo Pharma Chart

Okyo Pharma (OKYO) Discussions and Chat

Okyo Pharma Forums and Chat

Date	Time	Title	Posts
11/5/2021	08:25	OKYO Pharma PLC	528
17/4/2019	05:44	(OKYO) OKYO Pharma Says Data Shows Potential Of Its Dry Eye Treatment	6
17/4/2019	05:44	OKYO PHARMA (OKYO)	14

Add a New Thread

Okyo Pharma (OKYO) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
12:32:39	6.75	7,319	494.03	O
09:51:12	6.51	443	28.84	O
09:41:33	6.51	50,000	3,255.00	O
08:15:54	6.51	1,500	97.65	O
07:55:38	6.51	2,000	130.20	O

View all Okyo Pharma trades in real-time

Okyo Pharma (OKYO) Top Chat Posts

Date	Subject
11/5/2021 09:20	Okyo Pharma Daily Update: Okyo Pharma Limited is listed in the Mining sector of the London Stock Exchange with ticker OKYO. The last closing price for Okyo Pharma was 7p. Okyo Pharma Limited has a 4 week average price of 6.75p and a 12 week average price of 6.75p. The 1 year high share price is 18.75p while the 1 year low share price is currently 1p. There are currently 970,686,108 shares in issue and the average daily traded volume is 149,847 shares. The market capitalisation of Okyo Pharma Limited is £65,521,312.29. Read Full Thread Reply
21/1/2021 08:48	wd1010: Price target next few months? I've been holding this for many months as can see huge potential. Current pipeline...First is is the potential treatment for dry eye conditions, known as OK-113. Based on pre-clinical tests, the company believes its candidate could prove superior to the current leading dry-eye product in the market, Allergan's Restatis, which generates annual sales of US$1.2bn.A second asset on OKYO's books is a potential non-opioid pain relief product. This again is a huge market. Third is the latest development "OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat "cytokine storm" associated with COVID-19 and ARDS Read Full Thread Follow Reply
13/1/2021 10:54	chris2020: New betaville article out on Okyo, yesterday. Read Full Thread Follow Reply
11/10/2020 15:22	invester2010: note - teh dry eye market is multi-bllion dollar and OKYO has drug that meets the critiera for FDA appproval - hence big names on baord now. Read Full Thread Follow Reply
11/10/2020 15:17	invester2010: Now OKYO is duel listing Nadaq and expect FDA sumbmission of the their eye drug very soon - that could be next news pending - which will be send the s soaring over 30p - as this market is multi-billion dollar and OKYO is right at the center. we will have great week here. imho. Read Full Thread Follow Reply
18/9/2020 10:10	dodobird25: Volsung. You are evidently a committed OKYO investor. I also believe that the company has growth potential, and I intend to hold, through thick and thin, until the share price approaches double the current value, whenever that happens. Only then will I consider my position. My current holding is 200,000 shares @ approx. 11.1p ave. I have researched the company as fully as I am able, but from my experiences of other companies, I realise that there are investors out there with more detailed informatio than I am able to access. Should you have any information or insights, that you are willing to share, I would appreciate your input. Regards, and best wishes with your investments. Read Full Thread Follow Reply
18/9/2020 08:45	volsung: You’re a lovely piece of work aren’t you p5? Sad when other people’s losses are your joy in life. The share price will improve but your sad life probably won’t Read Full Thread Follow Reply
17/9/2020 15:55	dodobird25: Thank you for your reply. I am in total agreement, and I too should have sold when the OKYO share price was listed at around 18p. This has proven to be the case with other pharmaceuticals recently (TILS, SNG to mention two). No more FOMO for me - I have proven it to be a loser's game in the main part. From now on, I shall be selling, when a healthy profit has been achieved, and perhaps buying back if there is a significant pullback. I wish you well with your future investments. Your prediction regarding OKYO, when at its recent peak, has been proven to be correct. We should have a clearer indication as to where this share price is heading next week. I see nothing untoward in my research, but several companies, whose retail shareholders were anticipating significant growth following results, have come unstuck recently. Read Full Thread Follow Reply
06/8/2020 15:06	spurs90: Jim Mellon has just dumped his entire stake in tiddler Okyo Pharma, which is developing therapies for inflammatory eye diseases and chronic pain management. Below is a link to the announcement that shows he went down from owning just over 4pc to almost 0. Https://www.investegate.co.uk/okyo-pharma-limited--okyo-/rns/holding-s--in-company/202008060700092951V/ Now, that does seem a strange move by Mellon - a 'billionaire' investor that is said to be friends with Brexit leader Aaron Banks - given Okyo shares have been surging in recent weeks to almost 17p. Watching... Read Full Thread Follow Reply
28/7/2020 10:06	spurs90: OKYO Pharma Limited ("OKYO" or the "Company") Issue of convertible loan notes to raise £3,500,000 OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that it has raised £3,500,000 through the issue of convertible loan notes ("CLNs"). The proceeds of the CLNs will be used for working capital purposes as detailed below. The CLNs carry an interest rate of 2.15% compounding and have maximum term of 4 years. The CLNs convert into ordinary shares at a price of 8.5p per share. Conversion will be subject to shareholder approval and no conversions may take place prior to 28 February 2021. The CLNs were placed with a small number of private investors. OKYO intends to use the net proceeds received from the CLNs, to further the development of its clinical pipeline. The person who arranged for the release of this announcement on behalf of the Company was Keeren Shah, Chief Financial Officer of OKYO. Read Full Thread Follow Reply
24/7/2020 14:02	cumnor: Well, well, near 20 times jump in share price from placing price on no news that could remotely account for the rise-normally a company would come out with a 'we know no reason,,,,,' or 'if the directors have inside info relating to the rise it would of course, we presume, have been released if it is affecting the share price. But who knows? Big connections here with TILs-are its shareholders in for a reward, or a surprise re StemPrinter? Looking forward to see how the demerger transpires. imo Read Full Thread Follow Reply

Okyo Pharma share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

OKYO

Okyo Pharm..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20210511 14:28:54